In Re Glumetza Antitrust Litigation

UNITED STATES DISTRICT COURT

NORTHERN DISTRICT OF CALIFORNIA

In re No. C 19-05822 WHA GLUMETZA ANTITRUST No. C 19-06138 WHA LITIGATION. No. C 19-06839 WHA No. C 19-07843 WHA No. C 19-08155 WHA No. C 20-01198 WHA This Document Relates to: No. C 20-05251 WHA 12 HUMANA ACTION. (Consolidated)

ORDER RE MOTION

TO AMEND HUMANA

COMPLAINT

15 INTRODUCTION Plaintiff seeks leave to amend its complaint following dismissal for lack of standing. The time to amend has passed and plaintiff possessed both the law and facts necessary to plead to Article III’s satisfaction long ago. Good cause lacking, the motion is DENIED. STATEMENT Prior orders detailed this antitrust challenge to the marketing of brand and generic versions of the prevalent diabetes drug Glumetza. 336 F.R.D. 468 (N.D. Cal. 2020). Eleven months into this suit, months into discovery, and on…